KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Assets Average (2019 - 2025)

Historic Assets Average for Castle Biosciences (CSTL) over the last 7 years, with Q3 2025 value amounting to $553.8 million.

  • Castle Biosciences' Assets Average rose 1054.4% to $553.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $553.8 million, marking a year-over-year increase of 1054.4%. This contributed to the annual value of $492.3 million for FY2024, which is 931.6% up from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Assets Average is $553.8 million, which was up 1054.4% from $523.2 million recorded in Q2 2025.
  • Castle Biosciences' 5-year Assets Average high stood at $553.8 million for Q3 2025, and its period low was $426.1 million during Q2 2023.
  • Over the past 5 years, Castle Biosciences' median Assets Average value was $452.6 million (recorded in 2022), while the average stood at $466.2 million.
  • In the last 5 years, Castle Biosciences' Assets Average soared by 26527.04% in 2021 and then crashed by 597.82% in 2023.
  • Over the past 5 years, Castle Biosciences' Assets Average (Quarter) stood at $448.1 million in 2021, then grew by 0.99% to $452.6 million in 2022, then decreased by 1.74% to $444.7 million in 2023, then rose by 17.59% to $522.9 million in 2024, then rose by 5.9% to $553.8 million in 2025.
  • Its Assets Average stands at $553.8 million for Q3 2025, versus $523.2 million for Q2 2025 and $516.5 million for Q1 2025.